Make cancer treatment more effective and tolerable

Personalized prescription guidance for chemotherapy and supportive care medications

Pharmacogenomic (PGx) testing is emerging as a valuable tool to help guide prescription decisions in oncology. OneOme's RightMed® test is a PGx test that analyzes a patient's DNA to determine which medications and dosages may work best, providing valuable information to guide chemotherapy and supportive care decisions. The test covers medications commonly used in cancer care, including medications for chemotherapy, nausea/vomiting, pain, depression, anxiety, sleep, and more.

The RightMed test and the supporting RightMed oncology report may help you to more quickly identify the right medication or dose for a patient, leading to fewer adverse reactions, less trial and error, and more effective treatments.

Get a Sample RightMed oncology report

The Sample RightMed oncology report includes:

  • Both chemotherapies and palliative/supportive care medications, sorted by type of medication
  • Sample test results showing how medications are classified based on the severity of the predicted gene-drug interaction
  • A sample gene and phenotype summary for genes associated with the medications on the report

The RightMed test: Helping oncology patients get the right treatment or dose

The RightMed test covers hundreds of medications, including chemotherapies and supportive care medications. The RightMed oncology report includes medications relevant to oncology, grouped by category of drug and predicted gene-drug interaction (major, moderate, minimal). Providers also get access to relevant clinical guidelines, curated medication alternatives, and consults with OneOme's clinical team.


cancer icon

HOW THE RIGHTMED TEST MAY HELP WITH PERSONALIZED CHEMOTHERAPY DOSING

The RightMed test provides recommendations for specific chemotherapy dose adjustments to prevent toxicity and risk of side effects, based on a patient’s genes.

The RightMed test covers several chemotherapies commonly used for breast cancer, colorectal cancer, lung cancer, blood cancers, and more. The test includes both first-line therapies as well as several targeted therapies, also known as the tyrosine kinase receptor inhibitors (TKIs).

For a list of chemotherapy agents covered on the RightMed test download our Guide to the RightMed test for oncology.


plus icon

HOW THE RIGHTMED TEST MAY HELP WITH SUPPORTIVE CARE

The RightMed test covers many medications often prescribed for an oncology patient’s supportive care, including medications for pain, nausea, vomiting, sleep, hypertension, anxiety, depression, infection prophylaxis, and more.

By using the RightMed comprehensive test when prescribing medications for comorbidities, you may be able to find the right medication and dose faster, reduce the number of adverse drug reactions, and make your patients more comfortable.

For a list of supportive care conditions covered on the RightMed test download our Guide to the RightMed test for oncology.

The benefits of the RightMed test

The RightMed test can benefit providers, health systems, and patients by:

  • adverse icon
    Reducing adverse
    drug reactions


  • icon
    improve patient
    adherence

  • icon
    improve
    health and
    economic cost
    effectiveness


  • icon
    optimize dosing

  • icon
    change the
    prescribing
    paradigm from
    reactive
    to preventive

RightMed patient story

Pam

“The RightMed test results, for me, mean that I don’t have to be anxious or scared going into a procedure.”
— Pam
Read Pam's full story >

Ready to get started?

patient toolkit icon

Oncology report

VIEW A SAMPLE OF THE RIGHTMED ONCOLOGY REPORT.

form icon

TEST REQUISITION FORM

COMPLETE A SIMPLE TEST REQUISITION FORM TO PLACE YOUR FIRST ORDER.

toolkit icon

PROVIDER TOOLKIT

GET MORE INFORMATION, PLUS THE TOOLS YOU NEED TO GET STARTED.